CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- 4 Grant or award Director acquired 5,900 shares (grant or award)
- 4 Open-market buy Director bought 3,125,000 shares at $2.40 ($7,500,000)
- 4 Open-market buy Director bought 3,125,000 shares at $2.40 ($7,500,000)
- 4 Shares withheld for taxes SVP & Chief Medical Officer gave up 4,957 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,565 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 4,870 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,320 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 15,290 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 7,933 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Medical Officer gave up 8,093 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 9,069 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,096 shares (to pay taxes)
- 4 Open-market sale President & CEO sold 11,000 shares at an average $1.39 ($15,291)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 15 · 288 filings